These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2913343)

  • 1. Trichlormethiazide and oral phosphate therapy in patients with absorptive hypercalciuria.
    Insogna KL; Ellison AS; Burtis WJ; Sartori L; Lang RL; Broadus AE
    J Urol; 1989 Feb; 141(2):269-74. PubMed ID: 2913343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria.
    Coe FL; Parks JH; Bushinsky DA; Langman CB; Favus MJ
    Kidney Int; 1988 Jun; 33(6):1140-6. PubMed ID: 3404813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria.
    Van Den Berg CJ; Kumar R; Wilson DM; Heath H; Smith LH
    J Clin Endocrinol Metab; 1980 Nov; 51(5):998-1001. PubMed ID: 6893460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary hypophosphatemic rickets with hypercalciuria.
    Tieder M; Modai D; Samuel R; Arie R; Halabe A; Bab I; Gabizon D; Liberman UA
    N Engl J Med; 1985 Mar; 312(10):611-7. PubMed ID: 2983203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria.
    Preminger GM; Pak CY
    J Urol; 1987 Jun; 137(6):1104-9. PubMed ID: 3586136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal hypercalciuria and acidification defect in kidney stone patients.
    Nutahara K; Higashihara E; Ishiii Y; Niijima T
    J Urol; 1989 Apr; 141(4):813-8. PubMed ID: 2926870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria.
    Broadus AE; Insogna KL; Lang R; Ellison AF; Dreyer BE
    N Engl J Med; 1984 Jul; 311(2):73-80. PubMed ID: 6330548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological effects of slow release potassium phosphate for absorptive hypercalciuria: a randomized double-blind trial.
    Breslau NA; Heller HJ; Reza-Albarrán AA; Pak CY
    J Urol; 1998 Sep; 160(3 Pt 1):664-8. PubMed ID: 9720517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 1,25-dihydroxyvitamin D production in idiopathic hypercalciuria.
    Veenhuizen L; Donckerwolcke RA
    Child Nephrol Urol; 1991; 11(2):69-73. PubMed ID: 1756523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent nephrolithiasis: natural history and effect of phosphate therapy. A double-blind controlled study.
    Ettinger B
    Am J Med; 1976 Aug; 61(2):200-6. PubMed ID: 782240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical effects of a new slow-release potassium phosphate preparation (UroPhos-K) in absorptive hypercalciuria.
    Breslau NA; Padalino P; Kok DJ; Kim YG; Pak CY
    J Bone Miner Res; 1995 Mar; 10(3):394-400. PubMed ID: 7785460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained reduction in urinary calcium during long-term treatment with slow release neutral potassium phosphate in absorptive hypercalciuria.
    Heller HJ; Reza-Albarrán AA; Breslau NA; Pak CY
    J Urol; 1998 May; 159(5):1451-5; discussion 1455-6. PubMed ID: 9554331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary protein levels affect the excretion of oxalate and calcium in patients with absorptive hypercalciuria type II.
    Urivetzky M; Motola J; Braverman S; Smith AD
    J Urol; 1987 Apr; 137(4):690-2. PubMed ID: 3560323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal tubular function in children with hypercalciuria].
    Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
    Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal handling of calcium in hypercalciuric calcium oxalate nephrolithiasis.
    Colette C; Percheron C; Pham CT; Boniface H; Thomas N; Guiter J; Monnier L
    Miner Electrolyte Metab; 1993; 19(6):377-84. PubMed ID: 8164620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of oral calcium test in renal lithiasis].
    Robles-Páramo A; Chavez de los Rios JM; Cano LA; Cornejo TR
    Gac Med Mex; 1993; 129(2):151-5. PubMed ID: 7926397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.